Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
Real-time neurofeedback to target default mode network connectivity in individuals at clinical high-risk for psychosis
FY 2025-26
Summary
Psychotic disorders, such as schizophrenia, are among the most disabling mental health conditions worldwide. They often begin with a stage called clinical high-risk (CHR), when subtle symptoms and difficulties with thinking appear before illness fully develops. This period offers a critical window for early intervention, yet current treatments are limited and not designed to target the specific brain changes that occur at this stage.
This study will test a promising new approach called real-time neurofeedback, which uses brain imaging to help people learn to regulate their own brain activity. We will focus on a brain circuit called the default mode network (DMN), which shows different patterns of activity in people at risk for psychosis. These differences are linked to difficulties in thinking and feeling, and may reflect imbalances in important brain chemicals.
We will conduct a randomized trial with young adults at clinical high-risk for psychosis. Half will receive neurofeedback training that targets the DMN, and the other half will receive a comparison version. Before and after training, we will measure brain connectivity and brain chemistry using advanced imaging techniques. We will also compare these measures to a group of neurotypical participants.
This will be the first study to examine real-time neurofeedback in this population, and the first to combine it with measures of brain chemistry. Our goal is to determine whether this approach can shift brain activity toward healthier patterns and reveal how brain networks and chemicals interact in early psychosis. Findings will lay the foundation for personalized, brain-based strategies to support at-risk individuals and improve long-term outcomes.
Department
Program
Canada Postdoctoral Research Award (CPRA) program
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
536736
Name
Vandewouw Marlee M
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Real-time neurofeedback to target default mode network connectivity in individuals at clinical high-risk for psychosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Clinical High-Risk; Functional Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Personalized Intervention; Precision Mental Health; Psychosis; Real-Time Neurofeedback; Schizophrenia
Abstract
Psychotic disorders, such as schizophrenia, are among the most disabling mental health conditions worldwide. They often begin with a stage called clinical high-risk (CHR), when subtle symptoms and difficulties with thinking appear before illness fully develops. This period offers a critical window for early intervention, yet current treatments are limited and not designed to target the specific brain changes that occur at this stage.
This study will test a promising new approach called real-time neurofeedback, which uses brain imaging to help people learn to regulate their own brain activity. We will focus on a brain circuit called the default mode network (DMN), which shows different patterns of activity in people at risk for psychosis. These differences are linked to difficulties in thinking and feeling, and may reflect imbalances in important brain chemicals.
We will conduct a randomized trial with young adults at clinical high-risk for psychosis. Half will receive neurofeedback training that targets the DMN, and the other half will receive a comparison version. Before and after training, we will measure brain connectivity and brain chemistry using advanced imaging techniques. We will also compare these measures to a group of neurotypical participants.
This will be the first study to examine real-time neurofeedback in this population, and the first to combine it with measures of brain chemistry. Our goal is to determine whether this approach can shift brain activity toward healthier patterns and reveal how brain networks and chemicals interact in early psychosis. Findings will lay the foundation for personalized, brain-based strategies to support at-risk individuals and improve long-term outcomes.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Vandewouw, Marlee M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~